Frontiers in Oncology | Hematologic Malignancies

Brief Research Report

Published on 08 May 2024

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

in Hematologic Malignancies

Bruna Murbach
Gislaine Duarte
Leonardo Carvalho Palma
Eliana Miranda
Guilherme Duffles
Graziele Pavan Furlin
Isabella Toni
Carmino De Souza
Larissa Binelli
Vitor Leonardo Bassan

Frontiers in Oncology

doi 10.3389/fonc.2024.1393191

2,188 views

Case Report

Published on 03 May 2024

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

in Hematologic Malignancies

Annaïse J. Jauch
Ilaria Alborelli
Andreas Reusser
Albert Baschong
Cyrill Rütsche
Olivier Bignucolo
Jakob Passweg
Stefan Dirnhofer
Fatime Krasniqi

Frontiers in Oncology

doi 10.3389/fonc.2024.1296238

1,733 views
1 citation

Editorial

Published on 02 May 2024

Editorial: Reviews in hematologic malignancies: 2023

in Hematologic Malignancies

Billy Michael Chelliah Jebaraj
Michael Liew
Felix Seyfried

Frontiers in Oncology

doi 10.3389/fonc.2024.1412843

1,101 views

Original Research

Published on 02 May 2024

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

in Hematologic Malignancies

Claudia Núñez-Torrón Stock
Carlos Jiménez Chillón
Fernando Martín Moro
Juan Marquet Palomanes
Miguel Piris Villaespesa
Ernesto Roldán Santiago
Eulalia Rodríguez Martín
Anabelle Chinea Rodríguez
Valentín García Gutiérrez
Gemma Moreno Jiménez

Frontiers in Oncology

doi 10.3389/fonc.2024.1394648

1,343 views

Case Report

Published on 02 May 2024

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

in Hematologic Malignancies

Elisa Diral
Gloria Catalano
Maria Vittoria Cicinelli
Andrea Distefano
Sara Mastaglio
Luca Vago
Maria Teresa Lupo Stanghellini
Massimo Bernardi
Maurilio Ponzoni
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2024.1399894

926 views

Case Report

Published on 01 May 2024

Osteolytic lesions as a presenting sign of acute myeloid leukemia: a case report

in Hematologic Malignancies

Jingqian Zhang
Shidai Mu
Li Cai
Lisha Ai
Yaohui Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364266

1,349 views

Case Report

Published on 26 Apr 2024

A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine

in Hematologic Malignancies

Mengci Hu
Wenzhe Li
Pan Li
Jie Tan
Ya Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1329279

1,888 views
1 citation

Original Research

Published on 23 Apr 2024

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

in Hematologic Malignancies

Dong Won Baek
Ga-Young Song
Ho Sup Lee
Young Rok Do
Ji Hyun Lee
Ho-Young Yhim
Joon Ho Moon
Deok-Hwan Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1380492

1,413 views

Review

Published on 22 Apr 2024

Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing

in Hematologic Malignancies

Jianbiao Zhou
Wee-Joo Chng

Frontiers in Oncology

doi 10.3389/fonc.2024.1365330

5,085 views
3 citations

Mini Review

Published on 22 Apr 2024

Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma

in Hematologic Malignancies

Yifan Pang
Nilanjan Ghosh

Frontiers in Oncology

doi 10.3389/fonc.2024.1396395

2,969 views
1 citation

Correction

Published on 18 Apr 2024

Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

in Hematologic Malignancies

Mojtaba Azari
Maryam Barkhordar
Tanaz Bahri
Soroush Rad
Hosein Kamranzadeh Fumani
Seied Asadollah Mousavi
Sahar Tavakoli Shiraji
Morteza Azari
Parisa Shafaroudi
Mohammad Vaezi

Frontiers in Oncology

doi 10.3389/fonc.2024.1397607

640 views
1 citation

Review

Published on 18 Apr 2024

Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects

in Hematologic Malignancies

Charles J. Milrod
Ari Pelcovits
Thomas A. Ollila

Frontiers in Oncology

doi 10.3389/fonc.2024.1397053

2,244 views
5 citations

Brief Research Report

Published on 16 Apr 2024

A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing

in Hematologic Malignancies

Angelos Giannakoulas
Marios Nikolaidis
Grigorios D. Amoutzias
Nikolaos Giannakoulas

Frontiers in Oncology

doi 10.3389/fonc.2024.1390105

2,292 views
1 citation

Original Research

Published on 12 Apr 2024

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

in Hematologic Malignancies

Francesco Angotzi
Federica Lessi
Matteo Leoncin
Carla Filì
Mauro Endri
Albana Lico
Andrea Visentin
Stefano Pravato
Anna Candoni
Livio Trentin

Frontiers in Oncology

doi 10.3389/fonc.2024.1370405

2,524 views
1 citation

Original Research

Published on 12 Apr 2024

Central venous catheters do not increase the hemorrhagic risk in acute promyelocytic leukemia patients during induction therapy

in Hematologic Malignancies

Manxiong Cao
Jiaqiong Hong
Dongqing Zhang
Feiheng Chen
Yongzhong Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1332372

729 views

Original Research

Published on 11 Apr 2024

Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports

in Hematologic Malignancies

Philipp Faustmann
Jan C. Schroeder
Lucas Mix
Lennart Harland
Andreas Riedel
Wichard Vogel
Claudia Lengerke
Stefan Wirths

Frontiers in Oncology

doi 10.3389/fonc.2024.1384172

4,124 views
2 citations